I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003-2013, by ….) that were subject to more pharmaceutical innovation, controlling for changes in the age-standardized cancer incidence rate … of cancer drug innovation to Mexican longevity growth has been valuable, but, perhaps, it could have been even larger …

contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …

We analyze the association that pharmaceutical innovation had with premature mortality from all diseases in Switzerland … 2002-2019. The analysis is performed by investigating whether the diseases that experienced more pharmaceutical innovation … had larger subsequent declines in premature mortality and hospitalization. Pharmaceutical innovation is measured by the …

contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …

which suggests that the elasticity of innovation with respect to the expected price of drugs should be at least as great as … the elasticity of innovation with respect to expected market size (disease incidence). Then, the cross …-sectional relationship between pharmaceutical innovation and market size among a set of diseases (different types of cancer) exhibiting …

contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …

?s main objective is to assess the contribution of pharmaceutical innovation to the increase in cancer survival rates. Only … these differential rates of progress were partly attributable to different rates of pharmaceutical innovation for different … of pharmaceutical innovation to longevity increase I obtained in an earlier study, although that study was based on a …

chemotherapy innovation on the longevity of myeloma patients using both time-series US data and longitudinal data on 38 countries. …